ProQR Therapeutics NV (PRQR)
1.43
+0.02
(+1.42%)
USD |
NASDAQ |
Jun 11, 11:14
ProQR Therapeutics Debt to Equity Ratio : 0.364 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.364 |
| December 31, 2025 | 0.2834 |
| September 30, 2025 | 0.2556 |
| June 30, 2025 | 0.2244 |
| March 31, 2025 | 0.1913 |
| December 31, 2024 | 0.1754 |
| September 30, 2024 | 0.6319 |
| June 30, 2024 | 0.5373 |
| March 31, 2024 | 0.51 |
| December 31, 2023 | 0.4768 |
| September 30, 2023 | 0.459 |
| June 30, 2023 | 0.4157 |
| March 31, 2023 | 0.363 |
| December 31, 2022 | 0.3276 |
| September 30, 2022 | 0.3422 |
| June 30, 2022 | 0.6974 |
| March 31, 2022 | 0.5997 |
| December 31, 2021 | 0.5304 |
| September 30, 2021 | 0.2784 |
| June 30, 2021 | 0.2996 |
| March 31, 2021 | 0.6895 |
| December 31, 2020 | 0.6004 |
| September 30, 2020 | 0.4887 |
| June 30, 2020 | 0.0699 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1705 |
| December 31, 2019 | 0.1438 |
| September 30, 2019 | 0.1948 |
| June 30, 2019 | 0.1359 |
| March 31, 2019 | 0.1526 |
| December 31, 2018 | 0.101 |
| September 30, 2018 | 0.0812 |
| June 30, 2018 | 0.3508 |
| March 31, 2018 | 0.2615 |
| December 31, 2017 | 0.184 |
| September 30, 2017 | 0.198 |
| June 30, 2017 | 0.1654 |
| March 31, 2017 | 0.1005 |
| December 31, 2016 | 0.0865 |
| September 30, 2016 | 0.0878 |
| June 30, 2016 | 0.0743 |
| March 31, 2016 | 0.0642 |
| December 31, 2015 | 0.0539 |
| September 30, 2015 | 0.0404 |
| June 30, 2015 | 0.0419 |
| March 31, 2015 | 0.0266 |
| December 31, 2014 | |
| September 30, 2014 | 0.0252 |
| June 30, 2014 | 0.0808 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Pharming Group NV | 0.4321 |
| NewAmsterdam Pharma Co. NV | 0.00 |
| Kamada Ltd. | 0.0449 |
| Syndax Pharmaceuticals, Inc. | 8.298 |
| Opus Genetics, Inc. | -0.5658 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 114.11M |
| Total Liabilities (Quarterly) | 70.79M |
| Shareholders Equity (Quarterly) | 43.32M |
| Current Ratio | 2.481 |
| Net Debt Paydown Yield | 0.04% |